Clinical Trial Update: Effectiveness of 0.01% Atropine Sulfate Solution in Controlling of Myopia Progression in Children [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating 0.01% atropine sulfate solution for controlling myopia progression in children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopia

Drugs mentioned

• 0.01% Atropine Sulfate Solution (atropine sulfate)

Snippet

Sponsor: The V.P. Vyhodcev Eye Hospital | Conditions: Myopia | Phase 3 | Status: UNKNOWN